ROUND TABLE RESEARCH, INC.

Biotech

Engineered extracellular vesicles (EVs) derived from induced neural stem cells, loaded with TRAIL protein, for glioblastoma treatment

Grants
$305K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Advancing Extracellular Vesicle Therapy for Brain Cancer$305,031
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1092ByHeart, Inc.—$361M
1093BIOTECERA INC.——
1094Sidera Bio——
1095ROUND TABLE RESEARCH, INC.——
1096NANO-BEADS PROTEIN INNOVATIONS, INC.——
1097VORTEX THERAPEUTICS INC——
1098DARK MATTER THERAPEUTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.